AAPG · Ascentage Pharma Group International
Market Cap
$1.61B
Shares
93.39M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-20 | — | |
| 6-K | 2026-08-13 | — | |
| 6-K | 2026-08-05 | — | |
| 6-K | 2026-08-03 | — | |
| 6-K | 2026-07-27 | — | |
| 6-K | 2026-07-20 | — | |
| 6-K | 2026-07-13 | — | |
| 6-K | 2026-06-30 | — | |
| 6-K | 2026-06-15 | — | |
| 6-K | 2026-06-12 | 2026-06-11 | |
| 6-K | 2026-06-10 | — | |
| 6-K | 2026-06-01 | — | |
| 6-K | 2026-05-28 | 2026-05-27 | |
| 6-K | 2026-05-28 | — | |
| 6-K | 2026-05-22 | — | |
| 6-K | 2026-05-13 | — | |
| 6-K | 2026-05-12 | — | |
| 6-K | 2026-05-01 | 2026-04-30 | |
| 20-F | 2026-04-29 | 2025-12-31 | |
| 6-K | 2026-04-22 | — | |
| 6-K | 2026-04-20 | — | |
| 6-K | 2026-04-01 | — | |
| 6-K | 2026-03-26 | — | |
| 6-K | 2026-03-18 | — | |
| 6-K | 2026-03-16 | 2026-03-13 | |
| 6-K | 2026-03-11 | — | |
| 6-K | 2026-02-23 | — | |
| 6-K | 2026-02-09 | — | |
| 6-K | 2026-02-06 | — | |
| 6-K | 2026-01-15 | — | |
| 6-K | 2026-01-07 | — | |
| 6-K | 2025-12-31 | — | |
| 6-K | 2025-12-17 | — | |
| 6-K | 2025-12-09 | — | |
| 6-K | 2025-12-08 | — | |
| 6-K | 2025-12-05 | — | |
| 6-K | 2025-12-01 | — | |
| 6-K | 2025-11-28 | — | |
| 6-K | 2025-11-25 | — | |
| 6-K | 2025-11-19 | — | |
| 6-K | 2025-11-04 | — | |
| 6-K | 2025-10-30 | — | |
| 6-K | 2025-10-07 | — | |
| 6-K | 2025-08-28 | 2025-08-25 | |
| 6-K | 2025-08-21 | — | |
| 6-K | 2025-08-18 | — | |
| 6-K | 2025-08-08 | — | |
| 6-K | 2025-08-07 | — | |
| 6-K | 2025-08-01 | — | |
| 6-K | 2025-07-25 | — |
Showing 1–50 of 75 filings